This early-stage trial tests a new oral drug called cemsidomide (CFT7455) in about 224 adults with non-Hodgkin's lymphoma or multiple myeloma that has returned or not responded to prior therapies. The study aims to find safe doses and check for side effects, both when the drug is…
Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC